idoxifene

Known as: Pyr-I-Tam, 4-iodopyrrolidinotamoxifen, 1-[2-[4-[(1E)-1-(4-Iodophenyl)-2-phenyl-1-butenyl]phenoxy]ethyl]pyrrolidine 
A drug that blocks the effects of estrogen.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2016
0519912016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Oxidative stress plays a causative role in the development of hepatic fibrosis and apoptosis. Estradiol (E2) is an antioxidant… (More)
Is this relevant?
2003
2003
Oxidative stress plays a causative role in the development of hepatic fibrosis and apoptosis. Estradiol (E2) is an antioxidant… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
This paper describes a comparison between atmospheric pressure chemical ionization (APCI) and the recently introduced atmospheric… (More)
Is this relevant?
2001
2001
BACKGROUND/AIMS Idoxifene is a tissue-specific selective estrogen receptor modulator. Estradiol is a potent endogenous… (More)
Is this relevant?
2001
2001
1. The beneficial vasoprotective effects of oestrogens are hampered by their side effects on secondary sexual organs. Selective… (More)
Is this relevant?
2000
2000
Idoxifene is a novel selective estrogen receptor modulator. It has reduced agonist activity on breast and uterine cells compared… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
1999
1999
Idoxifene is a novel selective estrogen (E2) receptor (ER) modulator that is currently in clinical development for the treatment… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Antiestrogens such as tamoxifen are one of the most effective methods of treating estrogen receptor (ERalpha) positive breast… (More)
Is this relevant?
1999
1999
Idoxifene is a novel selective estrogen receptor modulator that has shown beneficial effects on bone turnover and lipid… (More)
Is this relevant?
1995
1995
Idoxifene, a novel antiestrogen with reduced estrogenic activity when compared to tamoxifen, has been given to 20 women with… (More)
Is this relevant?